Crosspoint Capital Strategies’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Crosspoint Capital Strategies’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,231	Closed	-$228K	–	1031
2015 Q4	$228K	Buy	+2,231	New	+$228K	0.06%	211
2014 Q2	–	Sell	-437	Closed	-$32K	–	720
2014 Q1	$32K	Buy	+437	New	+$30.5K	0.01%	317

Crosspoint Capital Strategies's COV Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2016, closing a stake of 2,231 shares — an estimated $228K sold.

Crosspoint Capital Strategies first reported a position in COV in Q1 2014 and held it in 2 quarters. The position peaked at $228K in Q4 2015. 0 funds tracked by Wall St. Rank hold COV as of Q1 2016.

Crosspoint Capital Strategies reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2016 after selling out during the quarter.
Crosspoint Capital Strategies sold 2,231 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2016, an estimated $228K.
Crosspoint Capital Strategies first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2014 and held it in 2 quarters.
Crosspoint Capital Strategies's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $228K in Q4 2015.
0 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.